Search

Your search keyword '"Achenbach H"' showing total 427 results

Search Constraints

Start Over You searched for: Author "Achenbach H" Remove constraint Author: "Achenbach H"
427 results on '"Achenbach H"'

Search Results

1. Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study

13. Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I–IV Non–Small Cell Lung Cancer

15. Mortality and bone safety outcomes in patients with end-stage renal disease receiving lanthanum carbonate: A long-term, observational study

16. Seltener Operationssitus in der Mittelohrchirurgie: Die persistierende Arteria stapedia als intratympanale Gefäßanomalie

18. LEUKEMIC TRANSFORMATION AND SECOND CANCERS IN 3649 HIGH RISK ET PATIENTS IN THE EXELS STUDY

21. Battery storage all but eliminates diesel generator

24. Treatment of high risk ET : data from the EXELS study

29. Treatment of essential thrombocythaemia in Europe : an observational study of 3649 high-risk patients in EXELS

31. Treatment Of Essential Thrombocythaemia In Europe : An Observational Study Of 3649 High-Risk Patients In Exels

32. Treatment Of Essential Thrombocythemia In Europe : Observational Study Of 3649 Patients Of High Risk (Exels)

33. Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study

36. Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients

37. Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC.

38. Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC

47. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers

48. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

Catalog

Books, media, physical & digital resources